Elsevier

Therapies

Volume 77, Issue 6, November–December 2022, Pages 747-749
Therapies

Letter to Editor
Adverse drug reactions associated with ivermectin use for COVID-19 reported in the World Health Organization's pharmacovigilance database

https://doi.org/10.1016/j.therap.2022.03.002Get rights and content

Keywords

Ivermectin
Pharmacovigilance
COVID-19

Cited by (0)

View Abstract